JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakuma, T.
Right arrow Articles by Kaul, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakuma, T.
Right arrow Articles by Kaul, S.
Journal of Nuclear Medicine Vol. 45 No. 7 1194-1200
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Molecular Imaging Identifies Regions with Microthromboemboli During Primary Angioplasty in Acute Coronary Thrombosis

Tadamichi Sakuma, MD, Jiri Sklenar, PhD, Howard Leong-Poi, MD, Norman C. Goodman, BSc, David K. Glover, PhD and Sanjiv Kaul, MD

Cardiovascular Imaging Center and Experimental Cardiology Laboratory, Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia

Microthromboemboli (MTE) may contribute to the no-reflow phenomenon in acute myocardial infarction (AMI) either spontaneously or after primary percutaneous transluminal coronary angioplasty (PTCA). We hypothesized that myocardial MTE in acute coronary syndromes can be identified on imaging by in vivo 99mTc labeling of the coronary thrombus with a compound that binds to the glycoprotein IIb/IIIa present on activated platelets (DMP-444). Methods: Fifteen dogs underwent left anterior descending coronary artery (LAD) injury in to produce thrombus, whereas 5 control dogs had LAD ligation. Before recanalization, the risk area (RA) and myocardial blood flow (MBF) were measured, and in vivo thrombus labeling was performed using 99mTc-labeled DMP-444. Nine of the 15 LAD injury dogs had occlusive thrombus on angiography and underwent PTCA. MBF measurements were repeated 30 and 60 min after recanalization, and 99mTc autoradiography (hot spot imaging) was performed ex vivo to determine the extent and magnitude of MTE. Results: The ratio of hot spot size to RA size was higher in the 9 LAD injury dogs with thrombus compared with the 6 dogs with no thrombus (90% ± 22% vs. 42% ± 16%; P = 0.005). In control dogs, this ratio was significantly lower (29% ± 11%; P = 0.05). 99mTc activity within the RA was higher in 8 of the 15 coronary injury dogs with AMI compared with those without AMI (1.8 ± 0.48 vs. 1.24 ± 0.22; P = 0.02). Conclusion: MTE can be detected and quantified after primary PTCA. The infarct size is proportional to the magnitude and extent of MTE, indicating that MTE may contribute to the AMI. Thus, in vivo thrombus labeling during reperfusion may provide important information in patients with AMI that may lead to better adjuvant therapy during PTCA.

Key Words: glycoprotein IIb/IIIa receptor • myocardial blood flow • autoradiography


Related articles in JNM:

This Month in JNM

JNM 2004 45: 13A-14A. [Full Text]  



This article has been cited by other articles:


Home page
CirculationHome page
S. Kaul
Myocardial Contrast Echocardiography: A 25-Year Retrospective
Circulation, July 15, 2008; 118(3): 291 - 308.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Sakuma, I. Sari, C. N. Goodman, J. R. Lindner, A. L. Klibanov, and S. Kaul
Simultaneous integrin {alpha}v{beta}3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty
Cardiovasc Res, June 1, 2005; 66(3): 552 - 561.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.